EXPRESSION OF HIV ANTIGENS IN E COLI
HIV 抗原在大肠杆菌中的表达
基本信息
- 批准号:3811240
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
DNA clones expressing portions of the gag, env, and pol genes of HIV in E.
coli have been isolated and characterized in order to derive information on
antigenic epitopes and to analyze reactivities of human sera at different
stages of virus infection. Eight clones expressing different regions of gag
gene proteins pl5, p24, and p17 have been generated by recombinant DNA
techniques. A ninth clone was prepared using the polymerase chain reaction
followed by standard cloning techniques. These 9 clones were used to map
epitopes on the gag gene recognized by a panel of monoclonal antibodies. A
manuscript describing these studies has been published and an invention
report filed. HIV integrase (IN) is a viral enzyme required for integration
of virus DNA into the host chromosome. As part of a collaborative project
with Dr. Judith Levin (NICHD/NIH) and Dr. Donald Court (FCRF) the pol clone
pWS4-1 has been subcloned to express only the integrase (IN) gene in order
to produce monospecific antisera. An IN clone was isolated which expresses
a fusion protein containing 27 amino acids of the RT and all of IN and the
protein was purified and used to immunize rabbits. The rabbit antisera are
reactive with HIV-1 IN but not HIV-2 IN by Western blot, and also reactive
with RT indicating that an antigenic epitope is present.in the terminal 27
amino acids of RT. An additional clone expressing only IN sequence has been
constructed using PCR, and the protein can be isolated from gels in
enzymatically active form. The recombinant protein and the assay we have
developed may be useful in large-scale screening for HIV antivirals and an
invention report has been filed. In addition, twenty-four hybridomas
expressing mAbs against IN and RT have been prepared and are being
subcloned and characterized.
在E.
大肠杆菌已被分离和表征,以获得信息,
抗原表位,并分析人血清在不同温度下的反应性,
病毒感染的阶段。八个克隆表达不同的gag区域
基因蛋白p15、p24和p17已经通过重组DNA产生
技术.使用聚合酶链反应制备第九克隆
然后是标准的克隆技术这9个克隆用于作图
由一组单克隆抗体识别的gag基因上的表位。一
描述这些研究的手稿已经出版,
报告存档。HIV整合酶(IN)是整合所需的病毒酶
病毒DNA进入宿主染色体。作为合作项目的一部分
与朱迪思·莱文博士(NICHD/NIH)和唐纳德·考特博士(FCRF)一起研究pol克隆
已将pWS 4 -1亚克隆以仅表达整合酶(IN)基因,
以产生单特异性抗血清。分离出IN克隆,其表达
含有RT和所有IN的27个氨基酸的融合蛋白,
纯化蛋白并用于免疫家兔。兔抗血清是
通过Western印迹,与HIV-1 IN反应,但不与HIV-2 IN反应,
其中RT表示抗原表位是present.in,末端27
仅表达IN序列的另外的克隆已经被克隆。
使用PCR构建,并且可以从凝胶中分离蛋白质,
酶活性形式。我们的重组蛋白和检测方法
开发可能是有用的,在大规模筛选艾滋病毒抗病毒药物,
发明报告已提交。此外,24个杂交瘤
已经制备了表达抗IN和RT的mAb,
亚克隆和表征。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
C J MARCUS-SEKURA其他文献
C J MARCUS-SEKURA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('C J MARCUS-SEKURA', 18)}}的其他基金
IMMUNOLOGIC ANALYSIS OF A HERPES VIRUS GLYCOPROTEIN VACCINE CANDIDATE--EBV GP350
疱疹病毒糖蛋白疫苗候选物--EBV GP350的免疫学分析
- 批准号:
3770329 - 财政年份:
- 资助金额:
-- - 项目类别:
ANALYSIS OF THE HIV INTEGRATION REACTION USING RECOMBINANT INTEGRASE
使用重组整合酶分析 HIV 整合反应
- 批准号:
3770330 - 财政年份:
- 资助金额:
-- - 项目类别:
INHIBITION OF GENE EXPRESSION BY NORMAL & MODIFIED ANTISENSE OLIGONUCLEOTIDES
正常情况下基因表达的抑制
- 批准号:
3804790 - 财政年份:
- 资助金额:
-- - 项目类别:
DETECTION OF VIRUSES IN CELL LINES USED TO MANUFACTURE BIOLOGICAL PRODUCTS
用于制造生物产品的细胞系中病毒的检测
- 批准号:
3770331 - 财政年份:
- 资助金额:
-- - 项目类别:
ANALYSIS OF THE HIV INTEGRATION REACTION USING RECOMBINANT INTEGRASE
使用重组整合酶分析 HIV 整合反应
- 批准号:
3748159 - 财政年份:
- 资助金额:
-- - 项目类别:
相似海外基金
Development of a new generation of antiviral agents that are effective against drug-resistant viruses and prevent serious illness and sequelae.
开发新一代抗病毒药物,可有效对抗耐药病毒并预防严重疾病和后遗症。
- 批准号:
23K18186 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
A versatile structure-based therapeutic platform for development of VHH-based antitoxin and antiviral agents
一个多功能的基于结构的治疗平台,用于开发基于 VHH 的抗毒素和抗病毒药物
- 批准号:
10560883 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
- 批准号:
10730692 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Design and synthesis of nucleosides to develop antiviral agents and oligonucleotide therapeutics
设计和合成核苷以开发抗病毒药物和寡核苷酸疗法
- 批准号:
21K06459 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (C)
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
- 批准号:
10189880 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Computer-aided identification and synthesis of novel broad-spectrum antiviral agents
新型广谱抗病毒药物的计算机辅助鉴定和合成
- 批准号:
2404261 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Studentship
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10222540 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10669717 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Association between sedentary lifestyle and liver cancer development in hepatitis C patients treated with direct-acting antiviral agents
接受直接抗病毒药物治疗的丙型肝炎患者久坐的生活方式与肝癌发展之间的关系
- 批准号:
20K10713 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (C)
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10174522 - 财政年份:2020
- 资助金额:
-- - 项目类别:














{{item.name}}会员




